Basic Information
| LncRNA/CircRNA Name | ENST00000551152 |
| Synonyms | |
| Region | GRCh38_12:38906451-38909592 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | Microarray, qPCR etc. |
| Sample | cell lines(HeLa, SiHa,MS751 and C34A), cervical cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | ENST00000551152 expression levels were closely associatedwith FIGO stage, tumor size, stromal invasion, pelvic lymphnode metastasis and SCC antigen expression level. Thus, ENST00000551152 shows great potential as a biomarker incervical cancer pathogenesis. |
| Pubmed ID | 29552195 |
| Year | 2018 |
| Title | Identification of lncRNAs by microarray analysis reveals the potential role of lncRNAs in cervical cancer pathogenesis. |
External Links
| Links for ENST00000551152 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |